Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Trading 0.2% Higher – What’s Next?

Shares of Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) rose 0.2% during trading on Thursday . The company traded as high as $25.32 and last traded at $25.34. Approximately 449 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 4,849 shares. The stock had previously closed at $25.28.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Performance

The firm’s 50 day moving average is $25.29 and its 200 day moving average is $25.36.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Wednesday, January 15th were issued a $0.5391 dividend. The ex-dividend date of this dividend was Wednesday, January 15th. This represents a $2.16 annualized dividend and a dividend yield of 8.53%. This is a boost from Harrow Health, Inc. 8.625% Senior Notes due 2026’s previous quarterly dividend of $0.54.

About Harrow Health, Inc. 8.625% Senior Notes due 2026

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.